Small genomic insertions form enhancers that misregulate oncogenes
Sequencing initiatives have detected multiple types of mutations in cancer. Here the authors, analysing enhancer-targeting sequence data, show that small insertions in transcriptional enhancers are frequently found near oncogenes, and demonstrate how one mutation deregulates expression of LMO2 in le...
Guardado en:
Autores principales: | Brian J. Abraham, Denes Hnisz, Abraham S. Weintraub, Nicholas Kwiatkowski, Charles H. Li, Zhaodong Li, Nina Weichert-Leahey, Sunniyat Rahman, Yu Liu, Julia Etchin, Benshang Li, Shuhong Shen, Tong Ihn Lee, Jinghui Zhang, A. Thomas Look, Marc R. Mansour, Richard A. Young |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/83aabc930e7b4c009b32aff780ab64f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correction: Corrigendum: Small genomic insertions form enhancers that misregulate oncogenes
por: Brian J. Abraham, et al.
Publicado: (2017) -
KRAS insertion mutations are oncogenic and exhibit distinct functional properties
por: Yasmine White, et al.
Publicado: (2016) -
Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic Diseases
por: Mustafa Karabicici, et al.
Publicado: (2021) -
Metabolome and proteome analyses reveal transcriptional misregulation in glycolysis of engineered E. coli
por: Chun-Ying Wang, et al.
Publicado: (2021) -
CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation
por: Rubina Tuladhar, et al.
Publicado: (2019)